Jun Xie1, Wei Song2, Xiaochun Liang3, Qian Zhang1, Yue Shi1, Wei Liu1, Xiaohu Shi1. 1. Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. 2. Center for Translational Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. 3. Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China. Electronic address: xcliang@vip.sina.com.
Abstract
OBJECTIVE: Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes with no effective drug currently. As a powerful antioxidant, the flavonoid quercetin has been demonstrated to have potential neuroprotective and prebiotic capacity. But the mechanism of its neuroprotective function and the link to the gut microbiota remains to be elucidated. METHODS: The neuroprotective effect of quercetin was evaluated on streptozotocin(STZ)-induced DPN rats through electrophysiology, behavioristic, and pathomorphology studies. Serum and urine reactive oxygen species (ROS) production levels and fecal gut microbiota compositions were detected, and the relationship between them was analyzed by Spearman's correlation. RESULTS: Quercetin not only reversed the decreased mechanical withdraw thresholds and intraepidermal nerve fiber densities in DPN rats, but also improved neurological morphology of sciatic nerves, accompanied with up-regulated percentage of paranodes at paranodal junctions, and down-regulated amyloid precursor protein and ionized calcium-binding adaptor molecule 1 in DPN rats. More importantly, quercetin rescued gut dysbiosis in DPN rats by decreasing four potential pathogenic species and enriching two prebiotic species associated with DPN phenotypes and ROS production levels. CONCLUSIONS: Quercetin exerts neuroprotective effect and modulates gut microbiota associated with DPN phenotypes and ROS production levels in STZ-induced DPN rats, suggesting the therapeutic application of quercetin for DPN prevention and treatment.
OBJECTIVE:Diabetic peripheral neuropathy (DPN) is a prevalent complication of diabetes with no effective drug currently. As a powerful antioxidant, the flavonoid quercetin has been demonstrated to have potential neuroprotective and prebiotic capacity. But the mechanism of its neuroprotective function and the link to the gut microbiota remains to be elucidated. METHODS: The neuroprotective effect of quercetin was evaluated on streptozotocin(STZ)-induced DPN rats through electrophysiology, behavioristic, and pathomorphology studies. Serum and urine reactive oxygen species (ROS) production levels and fecal gut microbiota compositions were detected, and the relationship between them was analyzed by Spearman's correlation. RESULTS:Quercetin not only reversed the decreased mechanical withdraw thresholds and intraepidermal nerve fiber densities in DPN rats, but also improved neurological morphology of sciatic nerves, accompanied with up-regulated percentage of paranodes at paranodal junctions, and down-regulated amyloid precursor protein and ionized calcium-binding adaptor molecule 1 in DPN rats. More importantly, quercetin rescued gut dysbiosis in DPN rats by decreasing four potential pathogenic species and enriching two prebiotic species associated with DPN phenotypes and ROS production levels. CONCLUSIONS:Quercetin exerts neuroprotective effect and modulates gut microbiota associated with DPN phenotypes and ROS production levels in STZ-induced DPN rats, suggesting the therapeutic application of quercetin for DPN prevention and treatment.
Authors: Erin C Mooney; Sara E Holden; Xia-Juan Xia; Yajie Li; Min Jiang; Camille N Banson; Bin Zhu; Sinem Esra Sahingur Journal: Front Immunol Date: 2021-11-26 Impact factor: 7.561
Authors: Victoria Anthony Uyanga; Felix Kwame Amevor; Min Liu; Zhifu Cui; Xiaoling Zhao; Hai Lin Journal: Nutrients Date: 2021-10-25 Impact factor: 5.717